QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:RCEL

AVITA Medical Stock Forecast, Price & News

$13.36
+0.46 (+3.57%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.10
$13.72
50-Day Range
$12.90
$19.66
52-Week Range
$12.62
$28.49
Volume
123,291 shs
Average Volume
137,812 shs
Market Capitalization
$333.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.08
30 days | 90 days | 365 days | Advanced Chart
Receive RCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.


AVITA Medical logo

About AVITA Medical

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product RECELL system is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company is headquartered in Valencia, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RCEL
Fax
N/A
Employees
2,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$29.23 million
Book Value
$4.47 per share

Profitability

Net Income
$-26.58 million
Pretax Margin
-71.40%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$333.00 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/08/2021
Today
12/07/2021
Next Earnings (Estimated)
2/10/2022
Fiscal Year End
6/30/2022

MarketRank

Overall MarketRank

2.14 out of 5 stars

Medical Sector

461st out of 1,394 stocks

Surgical & Medical Instruments Industry

50th out of 126 stocks

Analyst Opinion: 3.5Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












AVITA Medical (NASDAQ:RCEL) Frequently Asked Questions

Is AVITA Medical a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVITA Medical stock.
View analyst ratings for AVITA Medical
or view top-rated stocks.

How has AVITA Medical's stock been impacted by COVID-19 (Coronavirus)?

AVITA Medical's stock was trading at $6.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RCEL stock has increased by 119.7% and is now trading at $13.36.
View which stocks have been most impacted by COVID-19
.

When is AVITA Medical's next earnings date?

AVITA Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for AVITA Medical
.

How were AVITA Medical's earnings last quarter?

AVITA Medical, Inc. (NASDAQ:RCEL) posted its quarterly earnings results on Monday, November, 8th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.40) by $0.16. The business earned $7.02 million during the quarter, compared to analyst estimates of $6.98 million. AVITA Medical had a negative trailing twelve-month return on equity of 19.32% and a negative net margin of 71.51%. During the same quarter last year, the company earned ($0.48) EPS.
View AVITA Medical's earnings history
.

What guidance has AVITA Medical issued on next quarter's earnings?

AVITA Medical updated its second quarter 2022 earnings guidance on Monday, December, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $7 million-$7 million, compared to the consensus revenue estimate of $7.19 million.

What price target have analysts set for RCEL?

2 equities research analysts have issued 1-year target prices for AVITA Medical's shares. Their forecasts range from $27.00 to $41.00. On average, they expect AVITA Medical's share price to reach $34.00 in the next year. This suggests a possible upside of 154.5% from the stock's current price.
View analysts' price targets for AVITA Medical
or view top-rated stocks among Wall Street analysts.

Who are AVITA Medical's key executives?

AVITA Medical's management team includes the following people:
  • Michael S. Perry, Chief Executive Officer & Executive Director (LinkedIn Profile)
  • Kathy McGee, Chief Operating Officer
  • Michael B. Holder, Chief Financial Officer
  • Andrew Quick, Chief Technology Officer
  • Erin Liberto, Chief Commercial Officer

What other stocks do shareholders of AVITA Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Square (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO).

What is AVITA Medical's stock symbol?

AVITA Medical trades on the NASDAQ under the ticker symbol "RCEL."

Who are AVITA Medical's major shareholders?

AVITA Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.31%), Geode Capital Management LLC (1.68%), Pura Vida Investments LLC (1.01%), Bank of New York Mellon Corp (0.29%), Macquarie Group Ltd. (0.13%) and Morgan Stanley (0.11%). Company insiders that own AVITA Medical stock include David Mcintyre, Michael S Perry and Suzanne Crowe.
View institutional ownership trends for AVITA Medical
.

Which institutional investors are selling AVITA Medical stock?

RCEL stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Citigroup Inc., California State Teachers Retirement System, Morgan Stanley, Rafferty Asset Management LLC, Pura Vida Investments LLC, New York State Common Retirement Fund, and LPL Financial LLC.
View insider buying and selling activity for AVITA Medical
or view top insider-selling stocks.

Which institutional investors are buying AVITA Medical stock?

RCEL stock was purchased by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Raymond James & Associates, UBS Group AG, Bank of New York Mellon Corp, Millennium Management LLC, SG Americas Securities LLC, Geode Capital Management LLC, and BlackRock Inc.. Company insiders that have bought AVITA Medical stock in the last two years include David Mcintyre, and Suzanne Crowe.
View insider buying and selling activity for AVITA Medical
or or view top insider-buying stocks.

How do I buy shares of AVITA Medical?

Shares of RCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AVITA Medical's stock price today?

One share of RCEL stock can currently be purchased for approximately $13.36.

How much money does AVITA Medical make?

AVITA Medical has a market capitalization of $333.00 million and generates $29.23 million in revenue each year. The company earns $-26.58 million in net income (profit) each year or ($0.95) on an earnings per share basis.

How many employees does AVITA Medical have?

AVITA Medical employs 2,020 workers across the globe.

What is AVITA Medical's official website?

The official website for AVITA Medical is www.avitamedical.com.

Where are AVITA Medical's headquarters?

AVITA Medical is headquartered at 28159 Avenue Stanford Suite 220, Valencia CA, 91355.

How can I contact AVITA Medical?

AVITA Medical's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The company can be reached via phone at (833) 462-8482 or via email at [email protected].


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.